Area of research
Oncology · Genetics
Research interest
Research interests include CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Galectins and Cancer Biology, and Wnt/β-catenin signaling in development and cancer.
CD34 in preeclampsia: The role of endothelial cell pyroptosis and regulation by melatonin via melatonin membrane receptor 1
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy
Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia